| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM197211162872002 |
| P698 | PubMed publication ID | 4346707 |
| P50 | author | Sydney M. Finegold | Q19959431 |
| P2093 | author name string | Bartlett JG | |
| Sutter VL | |||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1006-1010 | |
| P577 | publication date | 1972-11-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Treatment of anaerobic infections with lincomycin and clindamycin. | |
| P478 | volume | 287 |
| Q36483975 | Anaerobic infection in cancer patients: comparative evaluation of clindamycin and cefoxitin |
| Q43748808 | Anaerobic infections in cancer patients — A retrospective analysis of clindamycin, tindazole, doxycycline, cefoxitin and lamoxactam |
| Q54051608 | Anaerobic infections in the newborn infant. |
| Q66843469 | Anaerobic infections of the female genital tract |
| Q93751117 | Anaerobic infections of the female genital tract: Bacteriologic and therapeutic aspects |
| Q40948378 | Anaerobic wound infections in cancer patients: comparative trial of clindamycin, tinidazole, and doxycycline |
| Q67374952 | Antibiotic concentration in human wound fluid after intravenous administration |
| Q54394821 | Antimicrobial in vitro susceptibility of actinomyces israelii and arachnia propionica. |
| Q35656719 | Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates |
| Q54623269 | Antimicrobial therapy of anaerobic infections |
| Q44047044 | Bacteroides Bacteraemia: A Clinical and Bacteriological Analysis of 51 Patients |
| Q54641278 | Beware — The Anaerobe Bandwagon |
| Q54643598 | Biochemical Characterization and in vitro Determination of Antibiotic Susceptibility of Clinical Isolates of Bacteroides fragilis |
| Q34910449 | Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice |
| Q70220864 | Clindamycin |
| Q50232276 | Clindamycin phosphate in severe infections mainly caused by Bacteroides fragilis: clinical and microbiological evaluation |
| Q33823463 | Clindamycin--efficacy and toxicity |
| Q66920983 | Clindamycin-associated colitis |
| Q55254391 | Clinical importance of infections due to Bacteroides fragilis and role of antibiotic therapy. |
| Q35212667 | Clinical relevance of antimicrobial susceptibility testing |
| Q72036346 | Diagnosis and treatment of intra-abdominal abscess in critically ill patients |
| Q71438572 | Diagnosis, prophylaxis and treatment of mixed (aerobic and anaerobic) infections following trauma or orthopaedic operation |
| Q33846331 | Effect of clindamycin and lincomycin therapy on faecal flora |
| Q70598977 | Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract |
| Q66908302 | Efficacy of Intravenous Clindamycin and Methicillin in Cram-positive Soft Tissue infections |
| Q40463124 | Equine pleuropneumonia |
| Q67235086 | Impact of Lactobacillus acidophilus on the normal intestinal microflora after administration of two antimicrobial agents |
| Q33730756 | In vitro antimicrobial susceptibility of Actinobacillus actinomycetemcomitans |
| Q68706416 | Infectious diseases: annual review of significant publications |
| Q54643072 | Lincomycin and clindamycin: their role in chemotherapy of anaerobic and microaerophilic infections. |
| Q35877334 | Newer Antibacterial and Antimycotic Drugs: Critical Appraisal |
| Q40145299 | Oral Antimicrobial Drugs |
| Q34916914 | Parenteral Clindamycin Phosphate: Pharmacology with Normal and Abnormal Liver Function and Effect on Nasal Staphylococci |
| Q42417794 | Pediatric antimicrobial therapy I. |
| Q36321667 | Physical characterization of Bacteroides fragilis R plasmid pBF4 |
| Q39355829 | Prophylactic oral antimicrobial agents in elective colonic surgery. A controlled trial |
| Q34911928 | Rapid microassays for clindamycin and gentamicin when present together and the effect of pH and of each on the antibacterial activity of the other |
| Q40162726 | Septicemia and Meningitis Caused by Fusobacterium Aquatile |
| Q54630290 | Some Clinical, Immunological and Bacteriological Observations in a Case of Pyogenic Arthritis due to Bacteroides Fragilis |
| Q40943384 | Susceptibility of Clostridium ramosum to antimicrobial agents |
| Q37151123 | Susceptibility testing of anaerobic bacteria |
| Q84203606 | Sydney M. Finegold |
| Q39927542 | The Newer Antibiotics |
| Q54591610 | The bacteriology of aspiration pneumonia |
| Q67287116 | The effect of cirrhosis on the disposition and elimination of clindamycin |
| Q36716969 | The penetration of metronidazole into synovial fluid |
| Q37437094 | The prevention of surgical site infection in elective colon surgery |
| Q41024096 | Tinidazole in the prevention of wound infection after elective colorectal surgery |
| Q41650265 | Transferable lincosamide-macrolide resistance in Bacteroides |
| Q28363600 | Treatment of Bacteroides infection with clindamycin-2-phosphate |
| Q66941026 | Treatment of Infections due to Nonsporing Anaerobes |
| Q40943057 | Treatment of anaerobic bacterial infections with clindamycin-2-phosphate |
| Q40944352 | Treatment of anaerobic infections with metronidazole |
| Q66896338 | Wound infections due to Bacteroides fragilis following intestinal surgery |
Search more.